Free Trial
NYSE:THC

Tenet Healthcare (THC) Stock Price, News & Analysis

Tenet Healthcare logo
$175.77 +2.11 (+1.22%)
As of 07/11/2025 03:59 PM Eastern

About Tenet Healthcare Stock (NYSE:THC)

Key Stats

Today's Range
$171.53
$175.96
50-Day Range
$148.80
$177.58
52-Week Range
$109.82
$178.76
Volume
946,825 shs
Average Volume
1.48 million shs
Market Capitalization
$16.33 billion
P/E Ratio
11.63
Dividend Yield
N/A
Price Target
$184.53
Consensus Rating
Moderate Buy

Company Overview

Tenet Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
94th Percentile Overall Score

THC MarketRank™: 

Tenet Healthcare scored higher than 94% of companies evaluated by MarketBeat, and ranked 58th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Tenet Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on 15 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Tenet Healthcare has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Tenet Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Tenet Healthcare are expected to grow by 9.80% in the coming year, from $12.24 to $13.44 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Tenet Healthcare is 11.63, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.85.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Tenet Healthcare is 11.63, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.26.

  • Price to Earnings Growth Ratio

    Tenet Healthcare has a PEG Ratio of 1.28. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Tenet Healthcare has a P/B Ratio of 2.87. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Tenet Healthcare's valuation and earnings.
  • Percentage of Shares Shorted

    3.84% of the float of Tenet Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Tenet Healthcare has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tenet Healthcare has recently decreased by 15.25%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Tenet Healthcare does not currently pay a dividend.

  • Dividend Growth

    Tenet Healthcare does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.84% of the float of Tenet Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Tenet Healthcare has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tenet Healthcare has recently decreased by 15.25%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Tenet Healthcare has a news sentiment score of 1.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 12 news articles for Tenet Healthcare this week, compared to 14 articles on an average week.
  • Search Interest

    Only 1 people have searched for THC on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Tenet Healthcare to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Tenet Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $8,846,305.00 in company stock.

  • Percentage Held by Insiders

    Only 0.81% of the stock of Tenet Healthcare is held by insiders.

  • Percentage Held by Institutions

    95.44% of the stock of Tenet Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Tenet Healthcare's insider trading history.
Receive THC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tenet Healthcare and its competitors with MarketBeat's FREE daily newsletter.

THC Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
See More Headlines

THC Stock Analysis - Frequently Asked Questions

Tenet Healthcare's stock was trading at $126.23 at the beginning of the year. Since then, THC shares have increased by 39.2% and is now trading at $175.77.

Tenet Healthcare Corporation (NYSE:THC) released its quarterly earnings results on Tuesday, April, 29th. The company reported $4.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.11 by $1.25. The business's quarterly revenue was down 2.5% compared to the same quarter last year.
Read the conference call transcript
.

Tenet Healthcare's Board of Directors authorized a stock buyback plan on Wednesday, July 24th 2024, which permits the company to buy back $1,500,000,000 in shares, according to EventVestor. This means that the company could buy up to 10.3% of its shares through open market purchases. Shares buyback plans are usually a sign that the company's management believes its shares are undervalued.

Tenet Healthcare subsidiaries include these companies: SurgCenter Development, United Surgical Partners International, European Surgical Partners Ltd., Aspen Healthcare, Emanuel Medical Center, Texas Regional Medical in Sunnyvale, Vanguard Health Systems, and others.

Tenet Healthcare's top institutional shareholders include Wedge Capital Management L L P NC (0.25%), Assenagon Asset Management S.A. (0.09%), Swedbank AB (0.07%) and Vista Investment Partners LLC (0.03%). Insiders that own company stock include Daniel J Cancelmi, Tammy Romo, James L Bierman, Richard J Mark, Nadja West, J Robert Kerrey, Paola M Arbour, Lisa Y Foo, Meghan Fitzgerald, Christopher S Lynch, Saumya Sutaria, Richard W Fisher, R Scott Ramsey and Thomas W Arnst.
View institutional ownership trends
.

Shares of THC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tenet Healthcare investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), TotalEnergies (TTE) and Southern First Bancshares (SFST).

Company Calendar

Last Earnings
4/29/2025
Today
7/13/2025
Next Earnings (Confirmed)
7/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - HOSPITALS
Sub-Industry
Health Care Facilities
Current Symbol
NYSE:THC
CIK
70318
Employees
98,000
Year Founded
1969

Price Target and Rating

High Price Target
$230.00
Low Price Target
$137.00
Potential Upside/Downside
+5.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.89
Research Coverage
19 Analysts

Profitability

EPS (Trailing Twelve Months)
$15.12
Trailing P/E Ratio
11.63
Forward P/E Ratio
14.36
P/E Growth
1.28
Net Income
$3.20 billion
Net Margins
7.09%
Pretax Margin
14.27%
Return on Equity
22.58%
Return on Assets
4.29%

Debt

Debt-to-Equity Ratio
2.23
Current Ratio
1.78
Quick Ratio
1.70

Sales & Book Value

Annual Sales
$20.67 billion
Price / Sales
0.79
Cash Flow
$21.10 per share
Price / Cash Flow
8.33
Book Value
$61.20 per share
Price / Book
2.87

Miscellaneous

Outstanding Shares
92,890,000
Free Float
92,133,000
Market Cap
$16.33 billion
Optionable
Optionable
Beta
1.64

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NYSE:THC) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners